1. Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug–drug interactions via CYP3A metabolism and transporters. Issue 4 (23rd January 2023) Authors: Barth, Aline; Perry, Caroline R.; Shabbir, Shaila; Zamek‐Gliszczynski, Maciej J.; Thomas, Sebin; Dumont, Etienne F.; Brimhall, Darin B.; Nguyen, Dung; Srinivasan, Meenakshi; Swift, Brandon Journal: Clinical and translational science Issue: Volume 16:Issue 4(2023) Page Start: 647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Design and Conduct Considerations for First‐in‐Human Trials. Issue 1 (24th August 2018) Authors: Shen, Jie; Swift, Brandon; Mamelok, Richard; Pine, Samuel; Sinclair, John; Attar, Mayssa Journal: Clinical and translational science Issue: Volume 12:Issue 1(2019) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Do we support our governments to use strict surveillance methods in the fight against the coronavirus?. (1st June 2020) Authors: Akhigbemen, Keziah; Bakare, Ade (Sherifat); Bingham, Hollie; Crossland, Eloise; Cupac, Matthew; Jones, Molly; Liew, Darill Zeng; McIvor, Shaunna; Nicosia, Katerina; Raval, Pooja; Shipley, Chris; Smith, Iona; Swift, Brandon; Tyson, Will; Williams, Leonie Journal: Journal of global faultlines Issue: Volume 7:Number 1(2020) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea. (21st November 2022) Authors: Scangarella-Oman, Nicole E; Hossain, Mohammad; Perry, Caroline R; Tiffany, Courtney; Powell, Marcy; Swift, Brandon; Dumont, Etienne F Journal: Sexually transmitted infections Issue: Volume 99:issue 1(2023) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Innovation at the Intersection of Clinical Trials and Real‐World Data Science to Advance Patient Care. Issue 5 (16th May 2018) Authors: Swift, Brandon; Jain, Lokesh; White, Craig; Chandrasekaran, Vasu; Bhandari, Aman; Hughes, Dyfrig A.; Jadhav, Pravin R. Journal: Clinical and translational science Issue: Volume 11:Issue 5(2018) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants. Issue 1 (5th December 2022) Authors: Barth, Aline; Hossain, Mohammad; Perry, Caroline R.; Gross, Annette S.; Ogura, Hirofumi; Shabbir, Shaila; Thomas, Sebin; Dumont, Etienne F.; Brimhall, Darin B.; Srinivasan, Meenakshi; Swift, Brandon Journal: Clinical pharmacology in drug development Issue: Volume 12:Issue 1(2023) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects. Issue 9 (13th July 2022) Authors: Tiffany, Courtney; Dumont, Etienne F.; Hossain, Mohammad; Srinivasan, Meenakshi; Swift, Brandon Journal: Clinical and translational science Issue: Volume 15:Issue 9(2022) Page Start: 2251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S19 Investigation of Linerixibat 40 Mg BID for Cholestatic Pruritus of Primary Biliary Cholangitis; Further Data From the Phase 2b GLIMMER Study to Support the Phase 3 GLISTEN Study. (October 2022) Authors: Fettiplace, James; Swift, Brandon; Zhang, Shu; Von Maltzahn, Robyn Other Names: McLaughlin Megan M. presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗